Found: 6
Select item for more details and to access through your institution.
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1607, doi. 10.3390/jpm12101607
- By:
- Publication type:
- Article
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 1, p. 55, doi. 10.3390/pharmaceutics16010055
- By:
- Publication type:
- Article
A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid Leukaemia.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1363, doi. 10.3390/pharmaceutics15051363
- By:
- Publication type:
- Article
Arterial hypertension assessment in a population with chronic myeloid leukemia.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94127-2
- By:
- Publication type:
- Article
Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 700, doi. 10.1002/ajh.24389
- By:
- Publication type:
- Article
Concentration of low-density lipoproteins (LDL) is significantly reduced after nilotinib discontinuation.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39057-x
- By:
- Publication type:
- Article